Filing Details

Accession Number:
0001062993-23-006320
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 20:00:15
Reporting Period:
2023-03-08
Accepted Time:
2023-03-08 20:00:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12208 Bio-Rad Laboratories Inc. BIO BIOB Laboratory Analytical Instruments (3826) 941381833
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1676291 S Timothy Ernst C/O Bio-Rad Laboratories, Inc.
1000 Alfred Nobel Drive
Hercules CA 94547
Evp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Bio-Rad A Common Stock Acquisiton 2023-03-08 850 $159.32 4,267 No 4 M Direct
Bio-Rad A Common Stock Acquisiton 2023-03-08 150 $215.98 4,417 No 4 M Direct
Bio-Rad A Common Stock Disposition 2023-03-08 1,000 $486.08 3,417 No 4 S Direct
Bio-Rad A Common Stock Disposition 2023-03-08 746 $486.89 2,671 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-03-08 850 $0.00 850 $159.32
Bio-Rad A Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-03-08 150 $0.00 150 $215.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-09-07 No 4 M Direct
2,350 2027-09-05 No 4 M Direct
Footnotes
  1. Includes 12.1510 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.
  2. The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.
  3. The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.